Advertisement
 
YOU ARE HERE: LAT HomeCollectionsGlucose Levels
IN THE NEWS

Glucose Levels

NEWS
February 2, 2011 | Janet Stobart / Los Angeles Times
A team of European doctors has tested an “artificial pancreas” aimed at helping pregnant women with Type 1 diabetes control their blood sugar. The goal? To lower their risk of having an abnormal birth or a fatal episode of hypoglycemia. Funded by the charitable foundation Diabetes UK , the research explores the during-pregnancy potential of a device the size of a cellphone. This "pancreas" has a continuous glucose monitor and an insulin pump that maintains a reliable level of blood sugar.
Advertisement
HEALTH
June 25, 2007 | From Times wire reports
Diabetes is dangerous even before the disease becomes full-blown, boosting the risk of death from heart disease in its earliest form, Australian researchers said last week. Before most people develop Type 2 diabetes, they have trouble metabolizing sugar, a problem known as pre-diabetes that affects 56 million people in the United States. Elizabeth Barr of the International Diabetes Institute in Melbourne, Australia and colleagues studied 10,429 Australians 25 or older for about five years.
BUSINESS
April 4, 1998 | Bloomberg News
Johnson & Johnson Co.'s LifeScan plant in Milpitas, Calif., was searched by investigators for the Justice Department and the Food and Drug Administration for evidence of possible criminal violations, the company and a law enforcement official said. The U.S.
BUSINESS
December 23, 1997
MiniMed Inc. has submitted an application to the U.S. Food and Drug Administration for approval of a glucose sensor that is inserted into the skin, an easier way of testing diabetes patients. Physicians must now draw blood from a patient several times a day to track glucose levels using traditional glucose meters and test strips. MiniMed's new system has a sensor that is inserted in the abdominal area and worn by patients for three days.
NEWS
August 6, 2001
Israeli researchers have succeeded in coaxing human embryonic stem cells into producing the hormone insulin in a key step toward creating a revolutionary treatment for juvenile diabetes. The findings, reported in the August issue of Diabetes, represent a major stride toward using embryonic stem cells to treat Type 1 diabetes, also known as juvenile diabetes.
NEWS
October 23, 2013 | By Mary MacVean
People with elevated blood sugar levels - even those not high enough for diabetes or pre-diabetes - are more likely to have memory problems than people with lower levels, a study of 141 people has shown. The results suggest that people within the normal range could help prevent cognitive problems as they age by lowering their blood sugar levels, said the author of the study, Agnes Floel of Charite University Medicine in Berlin. The work was published online Wednesday in the journal Neurology.
SCIENCE
October 15, 2012 | By Jon Bardin
Just a few nights of bad sleep is enough to throw the body's metabolism into disarray, according to a new study published Monday in the journal Annals of Internal Medicine. The study shows that getting four hours of sleep a night for four nights made healthy people's bodies resistant to insulin - a condition that is a common precursor of weight gain, diabetes and other serious health problems. In a healthy body, when you take in sugar, insulin is released from the pancreas and travels throughout the body, signaling to cells that they should absorb some of that new glucose.
NEWS
September 22, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
Liposuction patients are usually after one thing: a better-looking body. But a new study suggests the cosmetic procedure that removes fat from well-padded areas of the body may also reduce harmful fat circulating in the blood. Research to be presented Sunday at the annual meeting of the American Society of Plastic Surgeons in Denver was aimed at measuring triglyceride levels in 229 people having liposuction. In people with normal triglyceride levels, cosmetic surgery made no difference.
SCIENCE
October 24, 2009 | Shari Roan
A medication that is under review by the Food and Drug Administration for the treatment of type 2 diabetes may also promote weight loss, according to a study published online Thursday in the Lancet. The drug, liraglutide, was approved earlier this year in Europe for the treatment of diabetes. It is marketed under the brand name Victoza. Liraglutide is an injected drug that stimulates the release of insulin when glucose levels become too high. It also helps curb appetite. In the new study, researchers in Denmark assigned 564 obese people to one of four liraglutide doses, a placebo or the weight-loss drug orlistat.
NEWS
May 19, 2011 | By Marissa Cevallos, HealthKey / For the Booster Shots blog
Smart phones have already supplemented the doctor’s office and personal computers as sources of health advice — and now it appears car companies are driving into the on-the-go consumer health market. Ford is developing a way to display pollen counts and other allergen levels to drivers using its existing link to smart phone apps, the car company announced Wednesday. Ford has also made a prototype to synchronize glucose monitoring devices via Bluetooth. The car displays glucose levels and sounds an alert if they fall too low. A statement from Ford explains how this technology can help diabetics and allergy sufferers: “For people with diabetes and their caregivers, constant knowledge and control of glucose levels is critical to avoiding hypoglycemia or low glucose, which can cause confusion, lightheadedness, blurry vision and a host of other symptoms that could be dangerous while driving.
Los Angeles Times Articles
|